{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:49:06Z","timestamp":1773964146541,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.antiviral.2007.12.002","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T10:32:44Z","timestamp":1199788364000},"page":"215-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1"],"prefix":"10.1016","volume":"77","author":[{"given":"Brian B.","family":"Gowen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kie-Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence M.","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Sidwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.12.002_bib1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3201\/eid1003.020817","article-title":"Rift Valley fever encephalitis","volume":"10","author":"Alrajhi","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.002_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01310749","article-title":"Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters","volume":"114","author":"Anderson","year":"1990","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2007.12.002_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jir.1996.16.489","article-title":"The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon","volume":"16","author":"Blatt","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"issue":"Suppl. A","key":"10.1016\/j.antiviral.2007.12.002_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/14.suppl_A.27","article-title":"In-vivo activity of antivirals against exotic RNA viral infections","volume":"14","author":"Canonico","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"issue":"693","key":"10.1016\/j.antiviral.2007.12.002_bib5","first-page":"699","article-title":"Rift Valley fever\u2014Egypt, 1993","volume":"43","author":"Centers for Disease Control and Prevention (CDC)","year":"1994","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2007.12.002_bib6","first-page":"905","article-title":"Outbreak of Rift Valley fever\u2014Saudi Arabia, August\u2013October 2000","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2007.12.002_bib7","first-page":"1065","article-title":"Outbreak of Rift Valley fever\u2014Yemen, August\u2013October 2000","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2007.12.002_bib8","first-page":"73","article-title":"Rift Valley fever outbreak\u2014Kenya, November 2006\u2013January 2007","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2007.12.002_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3201\/eid1111.050869","article-title":"Emergence of Toscana virus in Europe","volume":"11","author":"Charrel","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.002_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1386-6532(02)00041-0","article-title":"Acute meningitis due to Toscana virus infection among patients from both the Spanish Mediterranean region and the region of Madrid","volume":"26","author":"Echevarria","year":"2003","journal-title":"J. Clin. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2007.12.002_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-3542(85)80028-0","article-title":"Efficacy of consensus interferon alpha against HSV-2 infections","volume":"5","author":"Fish","year":"1985","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.002_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.30.1.52","article-title":"Antitherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters","volume":"30","author":"Fish","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.12.002_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4269\/ajtmh.2003.69.269","article-title":"Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus","volume":"69","author":"Fisher","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.12.002_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0749-0720(02)00029-4","article-title":"Rift valley fever","volume":"18","author":"Gerdes","year":"2002","journal-title":"Vet. Clin. N. Am. Food Anim. Pract."},{"key":"10.1016\/j.antiviral.2007.12.002_bib15","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.49.6.2378-2386.2005","article-title":"Interferon alfacon-1 protects hamsters from lethal pichinde virus infection","volume":"49","author":"Gowen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.12.002_bib16","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.4049\/jimmunol.177.9.6301","article-title":"TLR3 deletion limits mortality and disease severity due to Phlebovirus infection","volume":"177","author":"Gowen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2007.12.002_bib17","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.01473-05","article-title":"Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters","volume":"50","author":"Gowen","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.12.002_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/095632020601700402","article-title":"Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters","volume":"17","author":"Gowen","year":"2006","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.12.002_bib19","first-page":"109","article-title":"Sandfly fever (pappataci, Phlebotomus, three-day fever)","volume":"vol. 7","author":"Hertig","year":"1964"},{"key":"10.1016\/j.antiviral.2007.12.002_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","article-title":"Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model","volume":"73","author":"Julander","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.002_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/095632020401500202","article-title":"Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models","volume":"15","author":"Morrey","year":"2004","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.12.002_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2004.02.005","article-title":"Modeling hamsters for evaluating West Nile virus therapies","volume":"63","author":"Morrey","year":"2004","journal-title":"Antiviral Res."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2007.12.002_bib23","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1093\/clinids\/11.Supplement_4.S815","article-title":"Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha","volume":"11","author":"Morrill","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.002_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01311288","article-title":"Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response","volume":"110","author":"Morrill","year":"1990","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2007.12.002_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/jir.1991.11.297","article-title":"Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey","volume":"11","author":"Morrill","year":"1991","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.antiviral.2007.12.002_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0923-2516(91)90070-J","article-title":"Rift Valley fever on the east coast of Madagascar","volume":"142","author":"Morvan","year":"1991","journal-title":"Res. Virol."},{"key":"10.1016\/j.antiviral.2007.12.002_bib27","unstructured":"NIAID, 2002. The Counter-Bioterrorism Research Agenda of the National Institute of Allergy and Infectious Diseases (NIAID) for CDC Category A Agents."},{"key":"10.1016\/j.antiviral.2007.12.002_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.01074-06","article-title":"The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist","volume":"81","author":"Perrone","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.12.002_bib29","series-title":"CRC Handbook Series of Zooneses, Section B","first-page":"403","article-title":"Rift Valley fever","author":"Peters","year":"1981"},{"key":"10.1016\/j.antiviral.2007.12.002_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2007.12.002_bib31","doi-asserted-by":"crossref","first-page":"S743","DOI":"10.1093\/clinids\/11.Supplement_4.S743","article-title":"Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted","volume":"11","author":"Peters","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.002_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3201\/eid1105.041122","article-title":"Toscana virus and acute meningitis","volume":"11","author":"Peyrefitte","year":"2005","journal-title":"Fr. Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.002_bib33","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2007.12.002_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/jir.1998.18.805","article-title":"The evolution of the type I interferons","volume":"18","author":"Roberts","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2007.12.002_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.1944.02850270001001","article-title":"Phlebotomous (pappataci or sandfly) fever: a disease of military importance. Summary of existing knowledge and report of original investigations","volume":"125","author":"Sabin","year":"1944","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2007.12.002_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10620-005-2564-2","article-title":"Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C","volume":"50","author":"Sjogren","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.antiviral.2007.12.002_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.510260330","article-title":"Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group","volume":"26","author":"Tong","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2007.12.002_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3748\/wjg.v13.i4.579","article-title":"Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study","volume":"13","author":"Witthoeft","year":"2007","journal-title":"World J. Gastroenterol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207004950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207004950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:25:01Z","timestamp":1759062301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207004950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0166354207004950"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.12.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}